In a report published by Goldman Sachs, analyst Andrew Rosivach initiated coverage on Healthcare Realty HR with a Sell rating and a $27 price target.
Goldman Sachs reported that, “We are initiating coverage on Healthcare Realty (HR) with a Sell rating, relative to our Attractive healthcare
coverage view, and a 12-month price target of $27 (2.8% potential upside including dividends vs. an average of +24.8% for our healthcare REIT coverage). Our FFO growth outlook through 2018 is excellent on the back of the lease-up of stabilization in progress (SIP) properties' potential external growth. However, HR's valuation anticipates earnings growth more than any other healthcare REIT under coverage.”
Shares of Healthcare Realty closed at $27.42 on Wednesday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in